[1] Gofton C,Upendran Y,Zheng MH,et al. NAFLD: How is it different from NAFLD? Clin Mol Hepatol,2023,29(1):17-31. [2] 窦科峰,杨西胜.外科医师应重视对代谢相关脂肪性肝病的认识.中华消化外科杂志,2021,20(1):40-45. [3] Kawaguchi T,Tsutsumi T,Nakano D,et al. NAFLD: Renovation of clinical practice and disease awareness of fatty liver. Hepatol Res,2022,52(5):422-432. [4] 朱桂新,梁永超,武爽.超声声衰减成像技术在评估非酒精性脂肪性肝病的初步探讨.中国超声医学杂志,2021,37(2):170-173. [5] 林颖鑫,孟健,冯蕾,等.声衰减成像在代谢相关脂肪性肝病分级诊断中的应用.中国医学影像学杂志,2023,31(10):1080-1102. [6] 中华医学会肝病学分会.代谢相关(非酒精性)脂肪性肝病防治指南(2024年版).中华肝脏病杂志,2024,32(5):418-434. [7] EslamM,Newsome PN,Sarin SK,et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.J Hepatol ,2020,73(1):202-209. [8] Pipitone RM,Ciccioli C,Infantino G,et al. NAFLD: a multisystem disease. Ther Adv Endocrinol Metab,2023,14(26):20420188221145549. [9] Kaya E,Yilmaz Y. Metabolic-associated fatty liver disease (NAFLD):a multi-systemic disease beyond the liver. J Clin Transl Hepatol,2022,10(2):329-338. [10] Yamamura S,Eslam M,Kawaguchi T,et al. NAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int,2020,40(12):3018-3030. [11] Isaacs S. Nonalcoholic fatty liver disease. Endocrinol Metab Clin North Am,2023,52(1):149-164. [12] 胡灵溪,安薪宇,李妹,等.超声衰减参数诊断体检人群脂肪肝临床应用价值分析.实用肝脏病杂志,2023,26(4):488-491. [13] Timaná J, Chahuara H, Basavarajappa L,et al. Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment. Sci Rep, 2023,13(1):8896-8898. [14] Welman CJ,Saunders J,Zelesco M,et al. Hepatic steatosis: ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation. J Med Imaging Radiat Oncol,2023,67(1):45-53. [15] Song K,Son NH,Chang DR,et al. Feasibility of ultrasound attenuation imaging for assessing pediatric hepatic steatosis. Biology (Basel),2022,11(7):1087-1089. [16] 候萌萌,苑喜微,王一奇,等.超声衰减参数在代谢相关脂肪性肝病诊断中的应用研究.中华肝脏病杂志,2022,30(3):290-296. [17] 张雨萌,张蕴显,王丹,等.超声弹性成像及生理参数在慢性肝病纤维化分级中的相关性分析.生物医学工程研究, 2022, 41(1):1-6. [18] 张姝嫔,程成,祝怡婕,等.超声衰减成像定量诊断非酒精性脂肪肝的应用价值初探讨.中国超声医学杂志,2021,37(1):718-722. [19] Welman CJ,Saunders J,Zelesco M,et al. Hepatic steatosis: ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation. J Med Imaging RadiatOncol,2023,67(1):45-53. [20] Song K,Son NH,Chang DR,et al. Feasibility of ultrasound attenuation imaging for assessing pediatric hepatic steatosis. Biology (Basel),2022,11(7):1087-1089. |